Recent research has identified RSΚ2 (encoded by the RPS6KA3 gene) as a new PIM2 targets, and its ectopic expression rescued the viability of PIM2-depleted cells, suggesting that RSΚ2 is downstream of PIM2 in pathways regulating AML cell survival 38. Here, PIM2 is linked to acute myeloid leukemia.